Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression. JIMKI. Published online December 10, 2025:4. doi:10.53366/jimki.vi.949